Skip to main content
editorial
. 2018 Oct 30;9(85):35515–35516. doi: 10.18632/oncotarget.26268

Figure 1. Many pro-oncogenic signaling pathways converge on cap-dependent translation and can be inhibited by targeting eIF4A.

Figure 1